Patents by Inventor Slavomir Bystricky

Slavomir Bystricky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals
    Patent number: 7563824
    Abstract: A clathrate formed by: a hyaluronic acid derivative (a), a hyaluronic acid derivative (b1) different from (a), and being able to form a clathrate with (a) and/or a component (b2) not containing a hyaluronic acid moiety but being able to form with (a) a clathrate and its use in the pharmaceutical field.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: July 21, 2009
    Assignee: Italian Joint Stock Company
    Inventors: Ladislav Soltes, Bohumil Steiner, Eva Machova, Grigorij Kogan, Slavomir Bystricky, Raniero Mendichi, Viktor Bauer, Mojmir Mach, Juraj Alfordi, Eva Stratilova
  • Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals
    Publication number: 20040076680
    Abstract: A clathrate formed by: a hyaluronic acid derivative (a), a hyaluronic acid derivative (b1) different from (a), and being able to form a clathrate with (a) and/or a component (b2) not containing a hyaluronic acid moiety but being able to form with (a) a clathrate and its use in the pharmaceutical field.
    Type: Application
    Filed: April 1, 2003
    Publication date: April 22, 2004
    Inventors: Ladislav Soltes, Bohumil Steiner, Eva Machova, Grigorij Kogan, Slavomir Bystricky, Raniero Mendichi, Viktor Bauer, Mojmir Mach, Juraj Alfldi, Eva Stratilova
  • Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide
    Patent number: 5738855
    Abstract: The present invention is a modified plant, fruit or synthetic oligo- or polysaccharide which has been structurally altered so as to render the modified saccharide antigenically similar to the Vi of Salmonella typhi. The modified saccharide may be conjugated to a carrier to form a conjugate that is immunogenic against S. typhi. Antibodies produced in response to the immunogenic conjugate are protective against typhoid fever. Methods are provided for making the modified saccharide and the immunogenic conjugate.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: April 14, 1998
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Shousun Chen Szu, Slavomir Bystricky